Advanced glycation end products induce secretion of chemokines and apoptosis in human first trimester trophoblasts

Human Reproduction

Volumn 19, Issue 9, 2004, Pages 2156-2162

  Konishi, H ^a   Nakatsuka, Mikiya ^a   Chekir, C ^a   Noguchi, S ^a   Kamada, Y ^a   Sasaki, A ^a   Hiramatsu, Y ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Advanced glycation end product; Apoptosis; Chemokines; Protease inhibitor; Trophoblasts

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; CHEMOKINE; CHORIONIC GONADOTROPIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; NAFAMSTAT MESILATE; NITRIC OXIDE SYNTHASE INHIBITOR; RANTES; SERINE PROTEINASE INHIBITOR; TRANSCRIPTION FACTOR;

APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CELLULAR DISTRIBUTION; CHORION VILLUS; CIGARETTE SMOKING; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; DIABETES MELLITUS; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIRST TRIMESTER PREGNANCY; GENE CONTROL; GESTATIONAL AGE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NICK END LABELING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; T LYMPHOCYTE; TROPHOBLAST; WESTERN BLOTTING;

EID: 4544224623     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/deh389     Document Type: Article

References (43)

1. Asagiri K, Nakatsuka M, Kimura Y, et al. (1998) Possible involvement of nitric oxide in LPS-induced apoptotic cell death in trophoblasts. In Moncada S, Toda N, Maeda Hs, and Higgs EA (eds) The Biology of Nitric Oxide. Part 6. Portland press, London, UK, 256 pp.
2. Asagiri K, Nakatsuka M, Konishi H et al. (2000) Expressions of chemokine receptors, CCR-4 and CCR-5, are altered in chorionic villi from patients with embryonal death. J Reprod Immunol 46,S28.
3. Baynes JW and Thorpe SR (2001) Glycoxidation and lipoxidation in atherogenesis. Free Radic Biol Med 28,1708-1716.
4. Bierhaus A, Chevion S, Chevion M et al. (1997) Advanced glycation end product-induced activation of NF-κB is suppressed by α-lipoic acid in cultured endothelial cells. Diabetes 46,1481-1490.
5. Blaschitz A, Weiss U, Dohr G and Desoye G (2000) Antibody reaction patterns in first trimester placenta: implications for trophoblast isolation and purity screening. Placenta 21,733-741.
6. Cerami C, Founds H, Nicholl I et al. (1997) Tobacco smoke is a source of toxic reactive glycation products. Proc Natl Acad Sci USA 94, 13915- 13920.
7. Chantakru S, Kuziel WA, Maeda N and Croy BA (2001) A study on the density and distribution of uterine Natural Killer cells at mid pregnancy in mice genetically-ablated for CCR2, CCR5 and the CCR5 receptor ligand, MIP-1α. J Reprod Immunol 49,33-47.
8. bright natural killer cells via the actions of monocyte inflammatory protein 1α. J Exp Med 193,1199-1212.
9. Garcia-Velasco JA and Arici A (1999) Chemokines and human reproduction. Fertil Steril 71,983-993.
10. Hori O, Brett J, Slattery T et al. (1995) The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J Biol Chem 270,25752-25761.
11. Ishii M, Hayakawa S, Suzuki MK et al. (2000) Expression of functional chemokine receptors of human placental cells. Am J Reprod Immunol 44, 365-373.
12. Kaji Y, Amano S, Usui T et al. (2003) Expression and function of receptors for advanced glycation end products in bovine corneal endothelial cells. Invest Ophthalmol Vis Sci 44,521-528.
13. Kamada Y, Nakatsuka M, Asagiri K et al. (2000) GnRH agonist suppressed expression of nitric oxide synthases and generation of peroxynitrite in adenomyosis. Hum Reprod 15,2512-2519.
14. Kirstein M, Brett J, Radoff S et al. (1990) Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging. Proc Natl Acad Sci USA 87,9010-9014.
15. Knowles RG, Merrett M, Salter M and Moncada S (1990) Differential induction of brain, lung, and liver nitric oxide synthase by endotoxin in the rat. Biochem J 270,833-836.
16. Kuniyasu H, Chihara Y and Kondo H (2003) Differential effects between amphoterin and advanced glycation end products on colon cancer cells. Int J Cancer 104,722-727.
17. Li YM, Baviello G, Vlassara H and Mitsuhashi T (1997) Glycation products in aged thioglycollate medium enhance the elicitation of peritoneal macrophages. J Immunol Methods 201,183-188.
18. Licht P, Russu V and Wildt L (2001) On the role of human chorionic gonadotropin (hCG) in the embryo-endometrial microenvironment: implications for differentiation and implantation. Semin Reprod Med 19,37-47.
19. Ligier S, Fortin PR and Newkirk MM (1998) A new antibody in rheumatoid arthritis targeting glycated IgG: IgM anti-IgG-AGE. Br J Rheumatol 37, 1307-1314.
20. Loske C, Neumann A, Cunningham AM et al. (1998) Cytotoxicity of advanced glycation end products is mediated by oxidative stress. J Neural Transm 105,1005-1015.
21. Loske C, Gerdemann A, Schepl W et al. (2000) Transition metal-mediated glycoxidation accelerates cross-linking of β-amyloid peptide. Eur J Biochem 267,4171-4178.
22. Min C, Kang E, Yu S-H et al. (1999) Advanced glycation end products induce apoptosis and procoagulant activity in cultured human umbilical vein endothelial cells. Diabetes Res Clin Pract (Suppl) 46,197-202.
23. Mohamed AK, Bierhaus A, Schiekofer S et al. (1999) The role of oxidative stress and NF-κB activation in late diabetic complications. Biofactors 10,157-167.
24. Moussa M, Mognetti B, Dubanchet S et al. (2001) Expression of β chemokines in explants and trophoblasts from early and term human placentae. Am J Reprod Immunol 46,309-317.
25. Nakatsuka M, Nakatsuka K and Osawa Y (1998) Metabolism-based inactivation of penile nitric oxide synthase activity by guanabenz. Drug Metab Dispos 26,497-501.
26. Nakatsuka M, Asagiri K, Kimura Y et al. (1999) Generation of peroxynitrite and apoptosis in placenta of patients with chorioamnionitis: possible implications in placental abruption. Hum Reprod 14,1101-1106.
27. Nakatsuka M, Asagiri K, Noguchi S et al. (2000) Nafamostat mesilate, a serine protease inhibitor, suppresses lipopolysaccharide-induced nitric oxide synthesis and apoptosis in cultured human trophoblasts. Life Sci 67, 1243-1250.
28. Neumann A, Schinzel R, Palm D et al. (1999) High molecular weight hyaluronic acid inhibits advanced glycation end product-induced NF-κB activation and cytokine expression. FEBS Lett 453,283-287.
29. Nicholl ID and Bucala R (1998) Advanced glycation end products and cigarette smoking. Cell Mol Biol 44,1025-1033.
30. Nilsson BO (1999) Biological effects of aminoguanidine: an update. Inflamm Res 48,509-515.
31. Noguchi S, Nakatsuka M, Konishi H et al. (2003) Nafamostat mesilate suppresses NF-κB activation and NO overproduction in LPS-treated macrophages. Int Immunopharmacol 3,1335-1344.
32. Ohmoto K, Neishi Y, Miyake I and Yamamoto S (1999) Severe acute pancreatitis associated with hyperlipidemia: report of two cases and review of the literature in Japan. Hepatogastroenterology 46,2986-2990.
33. Reape TJ and Groot PH (1999) Chemokines and atherosclerosis. Atherosclerosis 147,213-225.
34. Rodriguez-Garcia J, Requena JR and Rodriguez-Segade S (1998) Increased concentrations of serum pentosidine in rheumatoid arthritis. Clin Chem 44, 250-255.
35. Schmidt AM, Yan S-D, Wautier JL and Stern DM (1999) Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res 84,489-497.
36. Schmidt AM, Yan S-D, Yan S-F and Stern DM (2000) The biology of the receptor for advanced glycation end products and its ligands. Biochim Biophys Acta 1498,99-111.
37. Singh R, Barden A, Mori T and Beilin L (2001) Advanced glycation end-products: a review. Diabetologia 44,129-146.
38. Sugimoto H, Shikata K, Wada J et al. (1999) Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the overexpression of tumour necrosis factor-alpha and inducible nitric oxide synthase in diabetic rat glomeruli. Diabetologia 42,878-886.
39. Tsuchida K, Makita Z, Yamagishi S et al. (1999) Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195. Diabetologia 42,579-588.
40. Ulrich P and Cerami A (2001) Protein glycation, diabetes, and aging. Recent Prog Horm Res 56,1-21.
41. Vlassara H, Fuh H, Makita Z et al. (1992) Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model to diabetic and aging complications. Proc Natl Acad Sci USA 89,12043-12047.
42. Yamagishi S, Inagaki Y, Okamoto T et al. (2002) Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells. J Biol Chem 277,20309-20315.
43. Yui S, Sasaki T, Araki N et al. (1994) Induction of macrophage growth by advanced glycation end products of the Maillard reaction. J Immunol 152, 1943-1949.